CabotFRA:CBT -0.06%74 Days Payable is 76.63 as of Mar. 2026, which is 35% above its 10-year median of 56.72. GuruFocus rates FRA:CBT with a GF Score™ of 74/100 and a GF Value™ of €68.68 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,555 Chemicals companies, Cabot ranks better than 63.34% on this metric.
Cabot's average Accounts Payable for the
three
months ended in Mar. 2026 was €504 Mil. Cabot's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €600 Mil.
Hence, Cabot's Days Payable for the
three
months ended in Mar. 2026 was 76.63.
The historical rank and industry rank for Cabot's Days Payable or its related term are showing as below:
FRA:CBT'
s Days Payable Range Over the Past 10 Years
Min: 52.98 Med: 56.72 Max: 76.12
Current: 76.12
During the past 13 years, Cabot's highest Days Payable was 76.12. The lowest was 52.98. And the median was 56.72.
FRA:CBT's Days Payable is ranked better than 63.34% of 1555
companies
in the Chemicals industry
Industry Median: 59.95
vs FRA:CBT: 76.12
Cabot's Days Payable
declined
from Mar. 2025 (78.48) to Mar. 2026 (76.63).
It may suggest that Cabotaccelerated paying its suppliers.
Cabot Days Payable Related Terms
Cabot Days Payable Historical Data
* Premium members only.
The historical data trend for Cabot's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:CBT vs SXT, BCPC, PRM: Days Payable Comparison
For the Specialty Chemicals subindustry, Cabot's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cabot Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cabot's Days Payable distribution charts can be found below:
* The bar in red indicates where Cabot's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cabot's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cabot (FRA:CBT) has a Days Payable of 76.63 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cabot and its competitors. This is 35% above median its historical median of 56.72. Over the past decade, Cabot's Days Payable has ranged from 52.98 to 76.12. According to the industry distribution chart, Cabot ranks #570 out of 1555 companies in the Chemicals industry, placing it in the top 36.7%.
Is Cabot's Days Payable too high?
Cabot's current Days Payable of 76.63 is 35% above median its 10-year median of 56.72. Over the past 10 years, this metric has ranged from a low of 52.98 to a high of 76.12. The Chemicals industry median Days Payable is 59.95. Cabot's value of 76.63 is 27.8% above this industry median. Based on the distribution chart, Cabot ranks #570 out of 1555 companies in the Chemicals industry, which is above the industry midpoint. Overall, Cabot has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cabot's Days Payable compare to SXT and BCPC?
According to the Chemicals industry distribution chart, Cabot ranks #570 out of 1555 companies for Days Payable. This puts Cabot in the upper half of its industry. The industry median Days Payable is 59.95. Cabot's value of 76.63 is 27.8% above this benchmark. Historically, Cabot's own Days Payable has ranged from 52.98 to 76.12 over the past decade. While the company's 10-year median is 56.72 vs. the industry median of 59.95, Cabot has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.95, based on 1,555 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cabot's current Days Payable of 76.63 is 27.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cabot and its competitors. For the Chemicals industry, the median Days Payable is 59.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cabot's current Days Payable is 76.63, which is 35% above median its own 10-year median of 56.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabot stock overvalued right now?
Based on GuruFocus' analysis, Cabot (FRA:CBT) is currently considered Modestly Overvalued. The stock's GF Value™ is €68.68, compared to a current price of €78.60 — trading 14.4% above its estimated fair value. The current Days Payable is 76.63, which is 35% above median its 10-year median of 56.72 and 27.8% above the Chemicals industry median of 59.95. Cabot's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cabot (FRA:CBT), the current Days Payable is 76.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cabot (FRA:CBT) Overvalued in 2026?
Based on GuruFocus' analysis, Cabot stock appears to be overvalued.
The current stock price of €78.60 is trading 14.4% above its estimated GF Value™ of €68.68.
GuruFocus considers Cabot to be Modestly Overvalued.
Key valuation signals for FRA:CBT:
Days Payable: 76.63 (35% above median its 10-year median of 56.72)
GF Value™: €68.68 vs. price of €78.60 (14.4% above fair value)
Industry Position: 27.8% above the Chemicals median (#570 of 1555)
No single metric tells the full story. See the FRA:CBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
74GF Score
Get the complete analysis for FRA:CBT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CBT has been successfully added to your 
